05.21.14
SCA reported sales rose 4% to SEK 24.2 billion ($3.6 billion) while operating profit rose 14% to SEK 2.6 billion ($396 million). According to the company, the comparison of the first quarter of 2014 with the corresponding period previous year was affected by the divestments of Laakirchen and some Georgia-Pacific units as well as the acquisition of the majority shareholding in the Chinese company Vinda. The efficiency programs in the hygiene and forest products operations are continuing according to plan.
Consolidated net sales for the first quarter of 2014, excluding divestments, rose 9% compared with the same period a year ago. The increase is related to the acquisition of the majority shareholding in the Chinese company Vinda, higher volumes and higher prices. In emerging markets, growth, excluding exchange rate effects, remains favorable. The harsh winter in North America had a negative impact on demand and earnings for away-from-home tissue.
Consolidated net sales for the first quarter of 2014, excluding divestments, rose 9% compared with the same period a year ago. The increase is related to the acquisition of the majority shareholding in the Chinese company Vinda, higher volumes and higher prices. In emerging markets, growth, excluding exchange rate effects, remains favorable. The harsh winter in North America had a negative impact on demand and earnings for away-from-home tissue.